Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Get trade alerts by text
We text you when insiders, Congress or big funds make new trades. Free.
Macquarie Reiterates Outperform Rating on CACI International Inc
Macquarie has reiterated its Outperform rating on CACI International Inc with a price target of $780 following the company's recent performance.
Keefe, Bruyette & Woods Reiterates Outperform Rating on Everest Group
Keefe, Bruyette & Woods has reiterated its Outperform rating on Everest Group, lowering the price target to $407.
Barclays Reiterates Underweight Rating on Omega Healthcare Investors
Barclays has reaffirmed its Underweight rating on Omega Healthcare Investors, Inc. with a new price target of $48.00.
UBS Maintains Buy Rating for Omega Healthcare Investors, OHI
UBS has reaffirmed its Buy rating for Omega Healthcare Investors with a new price target of $52.00.
CIBC Reiterates Outperformer Rating on Talen Energy Corporation
CIBC maintains a bullish outlook on Talen Energy Corporation's stock with a price target of $499.
Citigroup Upgrades CEMEX, S.A.B. de C.V. to Buy
Citigroup has raised its rating on CEMEX, moving to a Buy with a new target price.
Citigroup Maintains Buy Rating on Aramark
Citigroup has reiterated its Buy rating for Aramark and raised its price target to $75.5.
TD Cowen Reiterates Buy Rating on Performance Food Group
TD Cowen has reiterated its Buy rating on Performance Food Group Company, lowering the target price to $110.
Morgan Stanley Reiterates Overweight Rating on Performance Food Group
Morgan Stanley has reaffirmed its positive outlook on Performance Food Group.
UBS Reiterates Buy Rating on The Carlyle Group Inc.
UBS keeps its Buy rating on Carlyle Group, lowering the price target to $60 amid shifting analyst perspectives.
Truist Securities Reiterates Buy Rating on Pinnacle Financial (PNFP)
Truist Securities has reiterated its Buy rating on Pinnacle Financial with a revised price target of $112.
Needham Maintains Buy Rating on Neurocrine Biosciences
Needham reaffirms its Buy rating on Neurocrine Biosciences, Inc. with a price target of $204.
Wells Fargo Reiterates Overweight Rating on Equitable Holdings
Wells Fargo has reaffirmed its Overweight rating on Equitable Holdings, Inc. with a new price target of $65.
Morgan Stanley Reiterates Overweight Rating on Hyatt Hotels
Morgan Stanley has reiterated its Overweight rating on Hyatt Hotels Corporation with a new price target of $211.00.
Freedom Broker Reiterates Buy Rating on Hyatt Hotels
Freedom Broker has reaffirmed its Buy rating for Hyatt Hotels Corporation with a price target of $192.
Citizens Reiterates Market Outperform Rating on Flutter Entertainment
Citizens has reiterated its Market Outperform rating on Flutter Entertainment, adjusting its price target to $129.
UBS Reiterates Buy Rating for Kimco Realty Corporation
UBS has reaffirmed its Buy rating on Kimco Realty with a target price of $25.00.
Piper Sandler Maintains Overweight Rating on Kimco Realty
Piper Sandler reiterates its Overweight rating on Kimco Realty with a new price target of $27.00.
B of A Securities Upgrades Weyerhaeuser Company to Buy
B of A Securities has raised its rating on Weyerhaeuser Company to Buy and set a price target of $25.
RBC Capital Maintains Outperform Rating on Weyerhaeuser Company
RBC Capital reiterates its positive stance on Weyerhaeuser, lowering the price target to $25 from $30.
Morgan Stanley Maintains Overweight Rating on Innio N.V.
Morgan Stanley reiterates its Overweight rating on Innio N.V. with a revised price target of $40 on October 14, 2026.
Morgan Stanley Reiterates Underweight Rating on APA Corporation
Morgan Stanley has reiterated its Underweight rating on APA Corporation, with a price target adjustment to $43.
Mizuho Reiterates Underperform Rating on APA Corporation
Mizuho continues to rate APA Corporation as Underperform with a revised price target.
Baird Reiterates Outperform Rating on James Hardie Industries
Baird has reiterated its Outperform rating on James Hardie Industries with a new price target of $32.00.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.